The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Anticipated Rise In Market Value Of The Antiemetics And Antinauseants Market During The Forecast Period?
The antiemetics and antinauseants market has experienced consistent expansion in recent years. This market is set to increase from $8.48 billion in 2025 to $8.72 billion in 2026, achieving a compound annual growth rate (CAGR) of 2.8%. Historically, this growth can be linked to factors such as a rise in cancer cases, an increase in surgical procedures, heightened awareness of chemotherapy’s side effects, the expansion of hospital and clinic facilities, and advancements in antiemetic drug formulations.
The antiemetics and antinauseants market is projected to experience consistent expansion in the coming years. Its valuation is anticipated to reach $10.01 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 3.5%. This forecasted increase can be linked to a higher incidence of motion sickness, an expanding global elderly population, the increasing embrace of personalized medicine, advancements in new antiemetic drug delivery methods, and the broadening of outpatient chemotherapy and palliative care offerings. Key developments expected during this period involve the creation of personalized anti-nausea treatments, innovative drug delivery systems, combined therapeutic strategies, a growing need for chemotherapy support, and an increase in treatments for motion sickness and travel-related conditions.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2441&type=smp
Which Drivers Are Supporting The Antiemetics And Antinauseants Market Growth?
The rising incidence of tuberculosis is anticipated to drive the expansion of the antiemetics and antinauseants market. Tuberculosis (TB) is a contagious bacterial illness primarily affecting the respiratory system. Antiemetic and antinauseant drugs are utilized to manage nausea and vomiting resulting from anti-tuberculosis treatments. For example, as reported by the Centers for Disease Control and Prevention, a US federal agency, in March 2025, the United States saw a provisional total of 10,347 tuberculosis cases in 2024, representing a rate of 3.0 cases per 100,000 population, which was an increase of approximately 8% compared with 2023. Consequently, the growing prevalence of tuberculosis is projected to stimulate the growth of the antiemetics and antinauseants market. The growing volume of surgical procedures is anticipated to fuel the expansion of the antiemetic and antinauseant market in the future. Surgery involves medical professionals using instruments to address injuries, illnesses, or conditions by operating on the body or repairing internal structures. The increase in surgical interventions is attributed to the rising incidence of chronic diseases that frequently necessitate operative care. Antiemetic and antinauseant medications are administered during surgeries to avert or alleviate postoperative nausea and vomiting induced by anesthesia and the surgical process itself. For example, the Australian Institute of Health and Welfare, an Australian government body, stated in April 2025 that public hospitals in 2023–24 recorded 778,500 admissions from elective surgery waitlists, indicating a 5.8% increase compared with 735,500 admissions in 2022–23. Consequently, the rising number of surgeries is propelling the growth of the antiemetic and antinauseant market.
Which Segment Classifications Are Used In The Antiemetics And Antinauseants Market Segment Analysis?
The antiemetics and antinauseants market covered in this report is segmented –
1) By Drug: Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types
2) By Application: Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types
3) By End Users: Hospital, Medical Center, Clinic, Research Institutes
Subsegments:
1) By Dopamine Antagonists: Metoclopramide, Prochlorperazine, Domperidone
2) By NK1 Receptor Antagonists: Aprepitant, Fosaprepitant, Rolapitant
3) By Antihistamines (H1 Histamine Receptor Antagonists): Dimenhydrinate, Meclizine, Diphenhydramine
4) By Cannabinoids: Dronabinol, Nabilone
5) By Benzodiazepines: Lorazepam, Diazepam
6) By Anticholinergics: Scopolamine, Glycopyrrolate
7) By Steroids: Dexamethasone, Methylprednisolone
8) By 5-HT3 Receptor Antagonists: Ondansetron, Granisetron, Palonosetron
9) By Other Drug Types: Herbal Remedies, Acupressure Devices
What Trends Are Transforming The Antiemetics And Antinauseants Market?
Leading companies in the antiemetic and antinauseant markets are engaged in developing novel product innovations, such as ready-to-use injectables, aimed at streamlining treatment protocols and improving patient adherence. These convenient formulations are designed to offer immediate efficacy, thereby reducing the time and complexity typically associated with traditional injectable medications. For instance, in July 2024, Amneal Pharmaceuticals, a US-based pharmaceutical company, launched FOCINVEZ, which is the first ready-to-use injectable formulation of fosaprepitant, specifically developed to prevent acute and delayed nausea and vomiting linked to highly emetogenic cancer chemotherapy. This product comes in a 150 mg/50 mL vial, is free of Polysorbate 80, and does not necessitate reconstitution or dilution, allowing for direct administration. FOCINVEZ is approved for use in adults and pediatric patients aged six months and older, and it has been assigned a unique J-Code (J1434) for reimbursement.
Which Firms Are Contributing To The Antiemetics And Antinauseants Market Ecosystem?
Major companies operating in the antiemetics and antinauseants market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Cipla Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Kyowa Hakko Kirin Pharma Co. Ltd., Daiichi Sankyo Company, Braun GmbH, Eisai Co. Ltd., Sun Pharmaceuticals Industries Ltd., Dr. Reddy’s Laboratories, Hikma Pharmaceuticals plc, IPCA Laboratories Ltd., Eagle Pharmaceuticals Inc., Cadila Pharmaceuticals Ltd., Bristol Laboratories Ltd., Tesaro Inc., SRS Pharmaceuticals Pvt. Ltd., Acacia Pharma Ltd., Algen Healthcare Ltd., Mirabilia Sciences Pvt. Ltd., Helsinn Healthcare SA
Get The Full Antiemetics And Antinauseants Market Report:
https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report
Which Region Is The Largest In The Antiemetics And Antinauseants Market?
North America was the largest region in the drugs for antiemetics and antinauseants market in 2025. The Middle East is expected to be the fastest-growing region in the global antiemetics and antinauseants market share. The regions covered in the antiemetics and antinauseants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Antiemetics And Antinauseants Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report
Browse Through More Reports Similar to the Global Antiemetics And Antinauseants Market 2026, By The Business Research Company
Antiemetics And Antinauseants Market Report 2026
https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report
Anti Infective Drugs Market 2026
https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-market
Anticholinergic Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/anticholinergic-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model